Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Napper

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Analytical Biochemistry|August 1, 2017
Beta-hairpin hydrogels as scaffolds for high-throughput drug discovery in three-dimensional cell culturePeter Worthington, Katherine M Drake, Zhiqin Li, et al.
SLAS Discovery : Advancing Life Sciences R & D|February 4, 2024
Perspectives on phenotypic screening-Screen Design and Assay Technology Special Interest GroupChorom Pak, Kaylene J Simpson, Andrea D Weston, et al.
ACS Chemical Biology|March 25, 2011
Identification of specific inhibitors of human RAD51 recombinase using high-throughput screeningFei Huang, Nuzhat A Motlekar, Chelsea M Burgwin, et al.
Yeast (Chichester, England)|October 25, 2007
A Saccharomyces cerevisiae cell-based quantitative beta-galactosidase assay compatible with robotic handling and high-throughput screeningRogerio Alves de Almeida, Danielle Burgess, Reut Shema, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2008
Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotypeMichael C Myers, Parag P Shah, Mary Pat Beavers, et al.
Assay and Drug Development Technologies|November 11, 2014
Controversies in ASSAY and drug development technologies: a focus on assessing irreproducibilityJ Fraser Glickman, Thomas Lundbäck, Andrew D Napper, et al.
Frontiers in Oncology|April 20, 2017
Cytotoxicity of Zardaverine in Embryonal Rhabdomyosarcoma from a Costello Syndrome PatientDonna M Cartledge, Katherine M Robbins, Katherine M Drake, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2007
Identification and characterization of 3-substituted pyrazolyl esters as alternate substrates for cathepsin B: the confounding effects of DTT and cysteine in biological assaysMichael C Myers, Andrew D Napper, Nuzhat Motlekar, et al.
Bioorganic & Medicinal Chemistry|December 9, 2009
Identification of triazinoindol-benzimidazolones as nanomolar inhibitors of the Mycobacterium tuberculosis enzyme TDP-6-deoxy-d-xylo-4-hexopyranosid-4-ulose 3,5-epimerase (RmlC)Sharmila Sivendran, Victoria Jones, Dianqing Sun, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2010
Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assayEdinson Lucumi, Claire Darling, Hyunil Jo, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Analytical Biochemistry|August 1, 2017
Beta-hairpin hydrogels as scaffolds for high-throughput drug discovery in three-dimensional cell culturePeter Worthington, Katherine M Drake, Zhiqin Li, et al.
SLAS Discovery : Advancing Life Sciences R & D|February 4, 2024
Perspectives on phenotypic screening-Screen Design and Assay Technology Special Interest GroupChorom Pak, Kaylene J Simpson, Andrea D Weston, et al.
ACS Chemical Biology|March 25, 2011
Identification of specific inhibitors of human RAD51 recombinase using high-throughput screeningFei Huang, Nuzhat A Motlekar, Chelsea M Burgwin, et al.
Yeast (Chichester, England)|October 25, 2007
A Saccharomyces cerevisiae cell-based quantitative beta-galactosidase assay compatible with robotic handling and high-throughput screeningRogerio Alves de Almeida, Danielle Burgess, Reut Shema, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2008
Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotypeMichael C Myers, Parag P Shah, Mary Pat Beavers, et al.
Assay and Drug Development Technologies|November 11, 2014
Controversies in ASSAY and drug development technologies: a focus on assessing irreproducibilityJ Fraser Glickman, Thomas Lundbäck, Andrew D Napper, et al.
Frontiers in Oncology|April 20, 2017
Cytotoxicity of Zardaverine in Embryonal Rhabdomyosarcoma from a Costello Syndrome PatientDonna M Cartledge, Katherine M Robbins, Katherine M Drake, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2007
Identification and characterization of 3-substituted pyrazolyl esters as alternate substrates for cathepsin B: the confounding effects of DTT and cysteine in biological assaysMichael C Myers, Andrew D Napper, Nuzhat Motlekar, et al.
Bioorganic & Medicinal Chemistry|December 9, 2009
Identification of triazinoindol-benzimidazolones as nanomolar inhibitors of the Mycobacterium tuberculosis enzyme TDP-6-deoxy-d-xylo-4-hexopyranosid-4-ulose 3,5-epimerase (RmlC)Sharmila Sivendran, Victoria Jones, Dianqing Sun, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2010
Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assayEdinson Lucumi, Claire Darling, Hyunil Jo, et al.
Pageof 4